Just skimmed thru the transcript. So many moving parts. Seems like GILD is willing to be aggressive with discounts / rebates, but will make sure that Doctors realize that their products are superior to Merck's and Abbvie's. Not just a commodity where price should be the only factor in the script decision.
June contract (front month) for crude is down 31 cents @ 45.61 as of about 10 minutes ago(delayed 10 mins).
Source......CME Group......could change much by morning of course.
Valeant and Perrigo combined would have way too much debt. Could deal with MYL, but the deal might have to be mostly for MYL stock. They have a fair amount of debt too, but nothing compared to VRX's $31 billion.
Kel................holding MYL and PRGO
I had DNDN too that day. Went from 7 into the 20's. Sold that day as |I had paid $4 a month earlier. But, Provenge was in great doubt regarding approval. N was pretty much a slam dunk, already priced in with the $3+ billion market cap.
Yes, approval moves the company from speculation to reality. Now, investors will be watching cash burn more closely, how quickly sales ramp, etc. The market cap of $3.5 billion has a lot of expectations already built in. Just my opinion as a former holder and now just an observer.
Still holding my ETJ in both accounts. I like it for a mid term holding. Sold CHI a few weeks ago for small gains.
Bought some CIEN (Ciena) today @ 16.66. Looks good (about 10 PE) based on next year's estimates. Near 52 week lows.
Mainly looking at the average estimates for fiscal year 2017 that ends on Oct. 31, 2017. EPS average estimate is for $1.67 vs the current year estimate of $1.32. Sales growth is predicted at 8.2%.
As of Jan. 31 they had cash of about $990 million (including LT investments) and debt of about $1.258 billion, some of it low cost convertible debt.
Getting to be quite a list........cost basis
MNTA @ 9.32
CELG @ 101.60
PRGO @ 105.36
MYL @ 44.69
ARWR @ 6.06
GILD @ 100.10
VNDA @ 8.68
non biotech.....CIEN @ 16.66
Good fortune hunting to all.............Kel
Would they be likely to dump the recently hired sales force and use their own? That's where most of the costs will be for the next few years...........just wondering.
Beware of the refiners. They move in multi year trends. They can go up for 2-5 years in a sawtooth type uptrend. Same thing when they turn bearish. Multi year downtrends then.
Kel..............just my observations.....no positions
Zepatier did $50 million of sales in the quarter. Further down in the report they break out the revs of each drug. Not much to brag about.
Bought some CSCO on Thursday @ 26.35. Not just a networking company anymore. Into "The Cloud," software, firewalls, and much more. A good play with it's low P/E ratio of just over 10 and their nearly 4% yield, with a growing div.
GILD now at 7 X PE ratio for 2016 estimates. Very washed out and a rising div too. It @ 85.16 on Friday.
Every time I tried I got a blank screen and a tab that said Yahoo "beta" message boards. OK now......Kel